In the present study, we examine the expression of BTLA, as well as its ligand HVEM (Herpesvirus Entry Mediator), on various B cell subsets in lupus patients compared to healthy controls (HCs). This evidence concerns the gene TNFRSF14 and systemic lupus erythematosus.